Table 4.
Subjects | Death | Hazard ratiof | 95% CI | |
---|---|---|---|---|
Rurala | ||||
Metropolitan | 32,408 | 11,911 | 1.00 | |
Rural | 4887 | 2074 | 1.07 | (1.03–1.13) |
Rural residence, with additional adjustmentsa | ||||
Stage | 1.07 | (1.02–1.12) | ||
Education | 1.06 | (1.00–1.13) | ||
Income | 1.11 | (1.05–1.18) | ||
Obesity | 1.07 | (1.02–1.12) | ||
Smoking | 1.07 | (1.02–1.12) | ||
Radiation and surgeryb | 1.06 | (1.01–1.12) | ||
Full model | 1.10 | (1.03–1.18) | ||
Other factors | ||||
Age at diagnosisc | ||||
<50 | 7274 | 1188 | 1.00 | |
50–64 years | 12,377 | 3349 | 1.79 | (1.66–1.92) |
65+ years | 17,644 | 9448 | 4.08 | (3.82–4.36) |
Raced | ||||
White | 36,248 | 13,520 | 1.00 | |
Black | 201 | 88 | 1.54 | (1.23–1.91) |
Other | 786 | 335 | 1.29 | (1.14–1.45) |
Unknown | 60 | 42 | 1.82 | (1.34–2.48) |
Hispanicd | ||||
No | 35,421 | 13,303 | 1.00 | |
Yes | 1874 | 682 | 1.21 | (1.11–1.31) |
Sexd | ||||
Male | 19,995 | 7808 | 1.00 | |
Female | 17,300 | 6177 | 0.94 | (0.91–0.98) |
Stagee | ||||
In situ | 3650 | 561 | 1.00 | |
Localized | 18,408 | 4202 | 1.89 | (1.71–2.08) |
Regional | 7168 | 2922 | 3.70 | (3.34–4.11) |
Distant | 6824 | 5256 | 10.75 | (9.66–11.96) |
Treatmente | ||||
No radiation or surgery | 8204 | 5566 | 1.00 | |
Radiation only | 4039 | 1815 | 0.71 | (0.67–0.76) |
Surgery only | 19,129 | 4951 | 0.28 | (0.27–0.30) |
Radiation and surgery | 5460 | 1350 | 0.32 | (0.30–0.35) |
Adjusted on age, sex, race/ethnicity, and cancer site.
No treatment, radiation only, surgery only, radiation, and surgery.
Adjusted on age, sex, race/ethnicity, rural residence, county‐level education, county‐level income, and cancer site.
Adjusted on age.
Adjusted on age, sex, race/ethnicity, rural residence, county‐level income, and cancer site.
Statistically significant HRs and 95%CIs are in bold